Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiunn H Lin

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Pharmaceutical Research|July 20, 2005
Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozilThomayant Prueksaritanont, Yue Qiu, Lillian Mu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2002
Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonizationThomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2Qin Mei, Karen Richards, Kristie Strong-Basalyga, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2006
In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studiesThomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 18, 2005
Hepatic uptake of the novel antifungal agent caspofunginPunam Sandhu, Wooin Lee, Xin Xu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Mechanistic studies on metabolic interactions between gemfibrozil and statinsThomayant Prueksaritanont, Jamie J Zhao, Bennett Ma, et al.
Chemical Research in Toxicology|February 18, 2003
Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteinsRominder Singh, Maria V Silva Elipe, Paul G Pearson, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strainsFengqi Zhang, Kevin T Chapman, William A Schleif, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virusZhijian Lu, Joann Bohn, Tom Rano, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Pharmaceutical Research|July 20, 2005
Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozilThomayant Prueksaritanont, Yue Qiu, Lillian Mu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2002
Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonizationThomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2Qin Mei, Karen Richards, Kristie Strong-Basalyga, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2006
In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studiesThomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 18, 2005
Hepatic uptake of the novel antifungal agent caspofunginPunam Sandhu, Wooin Lee, Xin Xu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Mechanistic studies on metabolic interactions between gemfibrozil and statinsThomayant Prueksaritanont, Jamie J Zhao, Bennett Ma, et al.
Chemical Research in Toxicology|February 18, 2003
Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteinsRominder Singh, Maria V Silva Elipe, Paul G Pearson, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strainsFengqi Zhang, Kevin T Chapman, William A Schleif, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virusZhijian Lu, Joann Bohn, Tom Rano, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.
Pageof 5